Data / New clinical trials / Lung Diseases, Interstitial
Lung Diseases, Interstitial trials: 142 new since Nov 2024
The full list. New Lung Diseases, Interstitial clinical trials: 142 rows for $7.10, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 7 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/lung-diseases-interstitial, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
142 clinical studies in Lung Diseases, Interstitial were first posted on ClinicalTrials.gov from November 13, 2024 to November 9, 2026; 24 have an industry sponsor and 109 are recruiting or about to. The newest, NCT07924462, was posted on November 9, 2026: Chronic Respiratory Disease Participant Engagement Study (Richmond Research Institute).
The request: Every new Lung Diseases, Interstitial clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 142New trials
- 24Industry sponsored
- 109Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 142, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07924462 | Chronic Respiratory Disease Participant Engagement Study | Richmond Research Institute | Observational | Recruiting | Interstitial Lung Disease (ILD), Chronic Respiratory Diseases, Alpha-1 Antitrypsin Deficiency (AATD), Chronic... | 500 | United Kingdom | clinicaltrials.gov |
| November 2, 2026 | NCT07910448 | TBLC vs NIVATS in Interstitial Lung Disease | Rita Alexandra Afonso da Costa | Not applicable | Not yet recruiting | Interstitial Lung Diseases (ILD) | 74 | Portugal | clinicaltrials.gov |
| October 14, 2026 | NCT07873931 | A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases | Bristol-Myers Squibb | Phase 1 | Not yet recruiting | Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies, Systemic... | 60 | Belgium, France, Germany, Netherlands, Poland, United States | clinicaltrials.gov |
| October 9, 2026 | NCT07867730 | Effects of Inspiratory Muscle Training and Positive Expiratory Pressure on Mechanically Ventilated Restrictive Lung Disease Patients | Foundation University Islamabad | Not applicable | Recruiting | Restrictive Lung Diseases | 30 | Pakistan | clinicaltrials.gov |
| October 6, 2026 | NCT07859839 | Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | Not yet recruiting | Interstitial Lung Disease | 177 | India | clinicaltrials.gov |
| September 28, 2026 | NCT07844915 | Artificial Intelligence Enhanced Remote Monitoring in Interstitial Lung Disease | King's College London | Not applicable | Not yet recruiting | Fibrotic Interstitial Lung Disease | 120 | United Kingdom | clinicaltrials.gov |
| September 28, 2026 | NCT07843381 | Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease | Peking University People's Hospital | Observational | Recruiting | Sjögren's Disease, Interstitial Lung Disease | 60 | China | clinicaltrials.gov |
| September 24, 2026 | NCT07839221 | Combined Growth Differentiation Factor-15 (GDF-15) and Lung Ultrasound for ILD Screening in Rheumatoid Arthritis and Systemic Sclerosis | Assiut University | Observational | Not yet recruiting | Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Interstitial Lung Disease (ILD) | 110 | clinicaltrials.gov | |
| September 23, 2026 | NCT07836790 | A Randomized, Double-Blind, Placebo-Controlled Trial of Fufei Huazhuo Tongluo Formula Combined With Standardized Medicine in Patients With... | First People's Hospital of Hangzhou | Not applicable | Not yet recruiting | Anti-Synthetase Syndrome, Interstitial Lung Disease (ILD) | 54 | China | clinicaltrials.gov |
| September 23, 2026 | NCT07836764 | Validation of 1 Minute Sit-to Stand Test for Assessment of Breathlessness at Exertion in Individuals With Chronic Lung Disease | Jacob Sandberg | Observational | Not yet recruiting | COPD (Chronic Obstructive Pulmonary Disease), Asthma (Diagnosis), Interstitial Lung Disease (ILD) | 120 | Sweden | clinicaltrials.gov |
| September 22, 2026 | NCT07833254 | Risk Factors of Venous Thrombotic Event in Interstitial Lung Disease | Sohag University | Observational | Not yet recruiting | Interstitial Lung Disease, Venous Thromboembolism, Pulmonary Embolism, Deep Venous Thrombosis | 100 | clinicaltrials.gov | |
| September 21, 2026 | NCT07830602 | Home-based Pulmonary Rehabilitation in Interstitial Lung Disease | Post Graduate Institute of Medical Education and Research, Chandigarh | Not applicable | Recruiting | Interstitial Lung Diseases | 80 | India | clinicaltrials.gov |
| September 18, 2026 | NCT07828054 | Premedication With Dexamethasone for Preventing Interstitial Lung Disease in Patients With Breast Cancer Treated With Trastuzumab Deruxtecan | Mario Negri Institute for Pharmacological Research | Phase 3 | Not yet recruiting | Breast Cancer, Interstitial Lung Disease (ILD) | 244 | clinicaltrials.gov | |
| September 15, 2026 | NCT07821398 | Hyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis | Bastiaan Driehuys | Phase 2 | Not yet recruiting | Interstitial Lung Disease, Pulmonary Hypertension, Systemic Sclerosis | 51 | clinicaltrials.gov | |
| September 14, 2026 | NCT07817563 | Study Evaluating 68GA-FAPI-46 PET/CT in Patients With Interstitial Lung Disease | Mayo Clinic | Phase 1 | Not yet recruiting | Interstitial Lung Disease | 10 | United States | clinicaltrials.gov |
| September 11, 2026 | NCT07816185 | A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier) | Pulmovant, Inc. | Phase 3 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases, Cardiovascular Diseases, Fibrosis | 376 | United States | clinicaltrials.gov |
| September 4, 2026 | NCT07805785 | A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary... | Insmed Incorporated | Phase 3 | Recruiting | Progressive Pulmonary Fibrosis, Interstitial Lung Disease | 800 | United States | clinicaltrials.gov |
| August 27, 2026 | NCT07791147 | Family-centred Pulmonary Rehabilitation to Empower Carers | Aveiro University | Not applicable | Not yet recruiting | Pulmonary Disease, Chronic Obstructive, Lung Diseases, Interstitial, Asthma, Lung Neoplasms, Bronchiectasis | 120 | Portugal | clinicaltrials.gov |
| August 27, 2026 | NCT07790822 | Cross-Regional Unmanned Aircraft Transport of Donor Lungs | The First Affiliated Hospital of Guangzhou Medical University | Not applicable | Not yet recruiting | Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), End-stage Lung Disease | 25 | China | clinicaltrials.gov |
| August 27, 2026 | NCT07790614 | Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis | Istituto Clinico Humanitas | Observational | Recruiting | IPF, ILD, Interstitial Lung Disease (ILD), Interstitial Lung Diseases, Idiopathic Pulmonary Fibrosis, Idiopathic... | 156 | Italy | clinicaltrials.gov |
| August 21, 2026 | NCT07780201 | Feasibility, Acceptability, and Implementability of I-IMPACT for ILD | University Hospitals, Leicester | Not applicable | Not yet recruiting | Interstitial Lung Disease (ILD) | 50 | clinicaltrials.gov | |
| August 20, 2026 | NCT07775235 | Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease | Singapore General Hospital | Observational | Recruiting | Interstitial Lung Disease, Myositis | 80 | Singapore | clinicaltrials.gov |
| August 12, 2026 | NCT07761377 | Retrospective Validation of AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CT | Taichung Veterans General Hospital | Observational | Recruiting | Pulmonary Fibrosis, Interstitial Lung Disease | 900 | Taiwan | clinicaltrials.gov |
| July 30, 2026 | NCT07737249 | Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease | Peking Union Medical College Hospital | Phase 2 | Not yet recruiting | Interstitial Lung Diseases | 60 | China | clinicaltrials.gov |
| July 27, 2026 | NCT07728448 | Predictors of Pulmonary Embolism in Interstitial Lung Disease With Worsening Symptoms | Assiut University | Observational | Not yet recruiting | Pulmonary Embolism, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Connective Tissue Disease-associated... | 70 | clinicaltrials.gov | |
| July 23, 2026 | NCT07723872 | Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease | Hospital de Granollers | Observational | Recruiting | Interstitial Lung Disease (ILD), Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis, Connective Tissue... | 100 | Spain | clinicaltrials.gov |
| July 22, 2026 | NCT07719218 | The Safety and PK Study of Inhaled ICF004 in Healthy Chinese Volunteers | Ruijin Hospital | Phase 1 | Not yet recruiting | Interstitial Lung Disease (ILD), Healthy Volunteers | 73 | clinicaltrials.gov | |
| July 20, 2026 | NCT07714252 | Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD | VA Office of Research and Development | Not applicable | Enrolling by invitation | Heart Failure, Pulmonary Disease, Chronic Obstructive, Interstitial Lung Disease | 420 | United States | clinicaltrials.gov |
| July 20, 2026 | NCT07712952 | Validation of AI-Based Detection of Idiopathic Pulmonary Fibrosis in Serial Chest Radiographs: A Retrospective Longitudinal Study | Chung-Ang University Hospital | Observational | Completed | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | 175 | South Korea | clinicaltrials.gov |
| July 16, 2026 | NCT07709260 | The Effects of Whole-Body Vibration Training on Clinical and Functional Outcomes in Individuals Diagnosed With Interstitial Lung Disease | Istinye University | Not applicable | Completed | Interstitial Lung Diseases | 26 | Turkey (Türkiye) | clinicaltrials.gov |
| July 7, 2026 | NCT07686562 | Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest Radiography | Chung-Ang University Hospital | Observational | Completed | Lung Disease, Interstitial, Idiopathic Pulmonary Fibrosis (IPF), Incidental Findings, Interstitial Lung Disease (ILD)... | 1,293 | South Korea | clinicaltrials.gov |
| July 1, 2026 | NCT07679854 | Nasal High-flow Oxygen Therapy During Rehabilitive Exercise Training in ILD | Frédéric Hérengt | Not applicable | Completed | Interstitial Lung Disease (ILD) | 60 | France | clinicaltrials.gov |
| June 29, 2026 | NCT07673237 | Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring | University of California, San Francisco | Not applicable | Recruiting | Fibrotic Interstitial Lung Disease, IPF and PPF, Lung Fibrosis Interstitial | 200 | United States | clinicaltrials.gov |
| June 24, 2026 | NCT07666841 | Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases | Tel-Aviv Sourasky Medical Center | Not applicable | Recruiting | COPD (Chronic Obstructive Pulmonary Disease), Rehabilitation, Bronchiectasis Adult, Pulmonary Arterial Hypertension... | 90 | Israel | clinicaltrials.gov |
| June 15, 2026 | NCT07648082 | Breathlessness Perceptions Within Respiratory Diseases | University Hospitals, Leicester | Observational | Recruiting | Chronic Obstructive Pulmonary Disease (COPD), Asthma (Diagnosis), Interstitial Lung Disease (ILD), Bronchiectasis... | 75 | United Kingdom | clinicaltrials.gov |
| June 8, 2026 | NCT07631507 | A Study to Evaluate the Diagnostic Performance of Portable Oscillometry Across Chronic Respiratory Diseases | The First Affiliated Hospital of Guangzhou Medical University | Observational | Not yet recruiting | COPD, Asthma (Diagnosis), Chronic Respiratory Diseases, Bronchiectasis, Interstitial Lung Disease (ILD), Upper Airway... | 4,000 | clinicaltrials.gov | |
| June 5, 2026 | NCT07628725 | VR-Assisted Exercise for Symptom Management and Rehabilitation in Interstitial Lung Disease | University of Manitoba | Not applicable | Not yet recruiting | Interstitial Lung Disease (ILD) | 32 | clinicaltrials.gov | |
| June 5, 2026 | NCT07628530 | Reference Equations and Normative Data for Isometric Quadriceps and Handgrip Muscles STrength in Southern European Populations - RESTart: a... | University of Alcala | Observational | Not yet recruiting | Muscle Strength, Healthy, Chronic Respiratory Diseases | 2,815 | Spain | clinicaltrials.gov |
| June 4, 2026 | NCT07627594 | Safety of Bronchoscopy in Patients With Interstitial Lung Disease | University of Milan | Observational | Not yet recruiting | Interstitial Lung Disease (ILD), Bronchoscopy, Bronchoalveolar Lavage (BAL), Acute Exacerbation, Cryobiopsy... | 427 | France, Italy | clinicaltrials.gov |
| May 29, 2026 | NCT07615504 | Better Tests- Improving Diagnostic Accuracy and Prognostication in Interstitial Lung Diseases | University of Dundee | Observational | Recruiting | Interstitial Lung Disease (ILD) | 750 | United Kingdom | clinicaltrials.gov |
| May 29, 2026 | NCT07613216 | A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of... | Cosmos Rx, Inc | Observational | Not yet recruiting | Idiopathic Pulmonary Fibrosis (IPF), Sarcoidosis Lung, Pulmonary Hypertension, Usual Interstitial Pneumonia | 100 | United States | clinicaltrials.gov |
| May 29, 2026 | NCT07613099 | Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | Recruiting | Allogeneic Stem Cell Transplantation, Lung Allograft Transplantation, Interstitial Lung Disease, Acute Lung Injury... | 210 | United States | clinicaltrials.gov |
| May 20, 2026 | NCT07599111 | Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP | Zhou Chengzhi | Phase 1/2 | Not yet recruiting | Pneumonitis, Interstitial, Immune Checkpoint Inhibitors (ICIs), Mesenchymal Stem Cells, Exosomes | 40 | clinicaltrials.gov | |
| May 19, 2026 | NCT07597187 | Clinical Utility of LIBS Multi-Element Imaging and the IFF Algorithm in Chronic Lung Diseases | University Hospital, Grenoble | Observational | Recruiting | Interstitial Lung Diseases (ILD), Pulmonary Emphysema, Chronic Lung Diseases, Occupational Lung Diseases, Environmental... | 70 | France | clinicaltrials.gov |
| May 12, 2026 | NCT07580053 | Hereditary Influences on Pulmonary Fibrosis Trajectories | Istituto Clinico Humanitas | Observational | Active not recruiting | Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder), Idiopathic Pulmonary Fibrosis (IPF)... | 250 | Italy | clinicaltrials.gov |
| May 11, 2026 | NCT07577115 | Occupational and Environmental Exposures Analysis in Interstitial Lung Diseases. | Istituto Clinico Humanitas | Observational | Active not recruiting | Interstitial Lung Disease Due to Systemic Disease (Disorder), Interstitial Lung Disease Due to Systemic Disease... | 1,000 | Italy | clinicaltrials.gov |
| May 7, 2026 | NCT07572383 | Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis | Peter Caravan | Phase 2 | Recruiting | Interstitial Lung Disease, Pulmonary Fibrosis | 15 | United States | clinicaltrials.gov |
| May 6, 2026 | NCT07570888 | This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis... | University of British Columbia | Phase 4 | Not yet recruiting | Pulmonary Fibrosis, Interstitial Lung Disease (ILD) | 120 | clinicaltrials.gov | |
| May 6, 2026 | NCT07570836 | Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung Disease | Shanghai Zhongshan Hospital | Phase 1 | Not yet recruiting | Interstitial Lung Disease (ILD) | 24 | China | clinicaltrials.gov |
| May 1, 2026 | NCT07561034 | The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease | University of Rochester | Not applicable | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease | 30 | United States | clinicaltrials.gov |
| April 30, 2026 | NCT07559435 | Diagnostic and Prognostic Utility of IL-6 and MMP-7 in Pediatric Immune Mediated Interstitial Lung Disease | Sohag University | Observational | Not yet recruiting | Pediatric Immune Mediated Interstitial Lung Disease | 60 | clinicaltrials.gov | |
| April 21, 2026 | NCT07541638 | Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Not applicable | Recruiting | Connective Tissue Diseases, Interstitial Lung Disease | 200 | Italy | clinicaltrials.gov |
| April 21, 2026 | NCT07540988 | FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression | Boehringer Ingelheim | Phase 3 | Recruiting | Interstitial Lung Diseases | 466 | Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Finland, France... | clinicaltrials.gov |
| April 20, 2026 | NCT07539701 | An Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy | Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | Not applicable | Active not recruiting | Lung Cancer (Diagnosis), Interstitial Lung Disease (ILD) | 30 | Canada | clinicaltrials.gov |
| April 6, 2026 | NCT07512687 | Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia | State University of New York at Buffalo | Not applicable | Enrolling by invitation | Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease, Hypoxemia | 24 | United States | clinicaltrials.gov |
| March 30, 2026 | NCT07500818 | Robotic-Assisted Versus Conventional Bronchoscopy for Cryobiopsy in the Diagnosis of Interstitial Lung Disease | University of Zurich | Not applicable | Recruiting | Interstitial Lung Disease (ILD), Lung Biopsy | 30 | Switzerland | clinicaltrials.gov |
| March 25, 2026 | NCT07493187 | Magnetic Resonance Imaging of the Lung: Non-Oncological Applications | Fondazione IRCCS Policlinico San Matteo di Pavia | Observational | Recruiting | Interstitial Lung Disease | 50 | Italy | clinicaltrials.gov |
| March 23, 2026 | NCT07486869 | Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study | University of Miami | Phase 2 | Recruiting | Dermatomyositis, Dermatomyositis Sine Myositis, Dermatomyositis With Myopathy, Dermatomyositis With Respiratory... | 5 | United States | clinicaltrials.gov |
| March 20, 2026 | NCT07486206 | Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial | Hospital de Granollers | Not applicable | Active not recruiting | Interstitial Lung Disease (ILD), Fibrotic Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis (IPF), Progressive... | 152 | Spain | clinicaltrials.gov |
| March 19, 2026 | NCT07482917 | Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial | Hospital de Granollers | Not applicable | Recruiting | Interstitial Lung Disease (ILD), Suspected Interstitial Lung Disease, Fibrotic Interstitial Lung Disease, Idiopathic... | 92 | Spain | clinicaltrials.gov |
| March 17, 2026 | NCT07478094 | Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost | University of Sao Paulo General Hospital | Observational | Completed | Pulmonary Hypertension Due to Lung Diseases | 72 | Brazil | clinicaltrials.gov |
| March 16, 2026 | NCT07473700 | Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease | Tectonic Operating Company, Inc. | Phase 2 | Recruiting | Hypertension, Pulmonary, Lung Diseases, Interstitial | 25 | Poland, Romania, Serbia, South Korea, Spain, United States | clinicaltrials.gov |
| March 9, 2026 | NCT07459179 | Clinical Study on the Application of PET Probes Targeting DDR2 in the Diagnosis of Interstitial Lung Disease With Cognitive Impairment | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Observational | Not yet recruiting | Interstitial Lung Disease | 50 | China | clinicaltrials.gov |
| March 9, 2026 | NCT07457502 | Domestic Environmental Exposure and Progression of ILD: An Exploratory Case-Control Study | Ville de Paris | Observational | Recruiting | Assess PID Diagnosis Revision After CMEI Audit, Assess CMEI Recommendations' Impact on Respiratory Health, ILD... | 100 | France | clinicaltrials.gov |
| March 5, 2026 | NCT07451977 | Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia | Istituti Clinici Scientifici Maugeri SpA | Not applicable | Recruiting | Chronic Respiratory Failure, Hypoxemia, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease | 114 | Italy | clinicaltrials.gov |
| March 2, 2026 | NCT07443436 | Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants | Assistance Publique - Hôpitaux de Paris | Phase 2 | Not yet recruiting | Interstitial Lung Disease | 30 | France | clinicaltrials.gov |
| February 25, 2026 | NCT07432503 | Diagnostic Yield and Safety of Lung Biopsy Techniques in Interstitial Lung Diseases | Mansoura University | Not applicable | Completed | Interstitial Lung Diseases (ILD), Hypersenstivity Pneumonitis | 60 | Egypt | clinicaltrials.gov |
| February 19, 2026 | NCT07420439 | Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease | Intergroupe Francophone de Cancerologie Thoracique | Phase 2 | Not yet recruiting | Non Small Cell Lung Cancer Metastatic, Interstitial Lung Disease (ILD) | 108 | France | clinicaltrials.gov |
| February 13, 2026 | NCT07411066 | Effects of Clinical Pilates on Physical and Psychosocial Outcomes in Individuals With Interstitial Lung Disease | Recep Tayyip Erdogan University | Not applicable | Not yet recruiting | Interstitial Lung Disease (ILD) | 58 | clinicaltrials.gov | |
| February 12, 2026 | NCT07406932 | A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease... | China-Japan Friendship Hospital | Not applicable | Recruiting | Antisynthetase Syndrome, Interstitial Lung Disease (ILD) | 80 | China | clinicaltrials.gov |
| February 9, 2026 | NCT07398287 | Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease | Region Skane | Phase 2 | Recruiting | Interstitial Lung Disease (ILD) | 20 | Sweden | clinicaltrials.gov |
| February 9, 2026 | NCT07396467 | Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis | The First Affiliated Hospital with Nanjing Medical University | Observational | Active not recruiting | Lung Cancer (Diagnosis), Pulmonary Fibrosis, Interstitial Lung Diseases | 200 | China | clinicaltrials.gov |
| February 2, 2026 | NCT07380152 | Corticosteroid Therapy in Pulmonary Sequelae of Covid-19 | University of Sao Paulo | Phase 1 | Completed | COVID-19 Pulmonary Complications | 100 | Brazil | clinicaltrials.gov |
| January 28, 2026 | NCT07372989 | Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease | Maule Stem Cell Research Institute, Inc. | Phase 1 | Recruiting | Lung Diseases, Interstitial | 50 | United States | clinicaltrials.gov |
| January 12, 2026 | NCT07333183 | A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD | Pulmovant, Inc. | Phase 2 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease (ILD), Lung Diseases, Vascular Diseases, Cardiovascular Diseases... | 20 | United States | clinicaltrials.gov |
| January 7, 2026 | NCT07323732 | A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease | Memorial Sloan Kettering Cancer Center | Phase 2 | Recruiting | NSCLC, NSCLC, Stage I, NSCLC Stage II, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer Stage I, Non-small Cell... | 25 | United States | clinicaltrials.gov |
| January 6, 2026 | NCT07320846 | The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis | Saglik Bilimleri Universitesi | Not applicable | Recruiting | Exercise, Pulmonary Rehabilitation, Interstitial Lung Disease, Long Noncoding RNA, Inspiratory Muscle Training... | 39 | Turkey (Türkiye) | clinicaltrials.gov |
| January 6, 2026 | NCT07319598 | A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease | Peking University Third Hospital | Phase 4 | Recruiting | Interstitial Lung Disease (ILD), Connective Tissue Disease-associated Interstitial Lung Disease | 100 | China | clinicaltrials.gov |
| January 2, 2026 | NCT07315425 | Acute Hemodynamic Responses to Blood Flow Restriction Aerobic Exercise in Interstitial Lung Disease | Gazi University | Not applicable | Active not recruiting | Interstitial Lung Disease (ILD) | 30 | Turkey (Türkiye) | clinicaltrials.gov |
| December 26, 2025 | NCT07305220 | Safety Profile of Ultrasound-guided Transparietal Lung Biopsy in Patients With Diffuse Interstitial Lung Disease | University Hospital, Tours | Not applicable | Not yet recruiting | Interstitial Lung Disease (ILD) | 15 | France | clinicaltrials.gov |
| December 24, 2025 | NCT07301892 | Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Observational | Completed | Rheumatoid Arthritis (RA, Osteoporosis, Osteoarthritis, Interstitial Lung Disease, Thyroid Diseases, Cardiovascular... | 57 | China | clinicaltrials.gov |
| December 24, 2025 | NCT07300696 | Functional MRI for Monitoring Progression and Assessing Trends in ILD | University Hospital Heidelberg | Not applicable | Recruiting | Interstitial Lung Diseases (ILD) | 200 | Germany | clinicaltrials.gov |
| December 16, 2025 | NCT07285655 | A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD | Liquidia Technologies, Inc. | Phase 3 | Recruiting | Pulmonary Hypertension Due to Lung Disease (Disorder) | 344 | Australia, Austria, Belgium, Canada, France, Germany, Italy, Latvia, Portugal... | clinicaltrials.gov |
| December 16, 2025 | NCT07284459 | Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis | Contineum Therapeutics | Phase 2 | Recruiting | Idiopathic Pulmonary Fibrosis | 324 | Argentina, Australia, Belgium, Canada, Chile, Denmark, France, Germany, Greece... | clinicaltrials.gov |
| December 15, 2025 | NCT07283081 | Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias | University Hospital, Bordeaux | Not applicable | Recruiting | Interstitial Lung Disease, Connective Tissue Diseases | 48 | France | clinicaltrials.gov |
| December 8, 2025 | NCT07269262 | SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers | Medical University of South Carolina | Not applicable | Recruiting | Progressive Pulmonary Fibrosis, Interstitial Lung Disease | 170 | United States | clinicaltrials.gov |
| November 28, 2025 | NCT07254338 | Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary... | Hospices Civils de Lyon | Observational | Recruiting | Interstitial Lung Disease, Precapillar Pulmonary Hypertension | 80 | France | clinicaltrials.gov |
| November 18, 2025 | NCT07234032 | An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With... | Insmed Incorporated | Phase 3 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease | 344 | Czechia, France, Georgia, Germany, Japan, South Korea, Spain, United States | clinicaltrials.gov |
| October 30, 2025 | NCT07222592 | MOBoxy: MoblO2 to Maintain Oxygenation | National Jewish Health | Not applicable | Not yet recruiting | COPD, Interstitial Lung Disease | 48 | United States | clinicaltrials.gov |
| October 6, 2025 | NCT07208201 | Bronchoalveolar Lavage in Interstitial Lung Diseases to Characterization of Specific Inflammatory Cellular Infiltrate in Different... | Maha Ahmed Abd EL Gawad Mohammed Okasha | Observational | Not yet recruiting | Interstitial Lung Diseases | 66 | clinicaltrials.gov | |
| October 1, 2025 | NCT07202260 | Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung | The Christie NHS Foundation Trust | Observational | Active not recruiting | Lung Cancer (NSCLC), Lung Cancer (SCLC) | 80 | United Kingdom | clinicaltrials.gov |
| October 1, 2025 | NCT07201922 | A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis | Boehringer Ingelheim | Phase 3 | Recruiting | Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases | 80 | Argentina, Australia, Belgium, Canada, France, Germany, Italy, Japan... | clinicaltrials.gov |
| September 18, 2025 | NCT07181382 | Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | GB002, Inc. | Phase 3 | Suspended | Pulmonary Hypertension Associated With Interstitial Lung Disease | 480 | Israel, United States | clinicaltrials.gov |
| September 17, 2025 | NCT07179380 | Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With... | Insmed Incorporated | Phase 3 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease | 344 | Argentina, Australia, Austria, Belgium, Brazil, Colombia, Czechia, Denmark... | clinicaltrials.gov |
| September 16, 2025 | NCT07175038 | A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung... | AllRock Bio, Inc. | Phase 2 | Recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease | 40 | Australia, Canada, France, Germany, Italy, Latvia, Poland, Spain, United States | clinicaltrials.gov |
| September 15, 2025 | NCT07174102 | Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography | Azienda Unita Sanitaria Locale di Piacenza | Observational | Recruiting | Reumatoid Arthritis, Interstitial Lung Disease Due to Systemic Disease (Disorder), Idiopathic Pulmonary Fibrosis (IPF)... | 500 | Czechia, Italy | clinicaltrials.gov |
| September 15, 2025 | NCT07173348 | Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea | University Hospital, Geneva | Not applicable | Recruiting | Cancer (With or Without Metastasis), Interstitial Lung Disease (ILD), Chronic Heart Failure (CHF), COPD, Dyspnea | 82 | Switzerland | clinicaltrials.gov |
| September 11, 2025 | NCT07169253 | Prognostic Score Comparison in IPF and HP | Saglik Bilimleri Universitesi | Observational | Completed | IPF, Fibrotic Lung Disease, Hypersensitivity Pneumonitis, Interstitial Lung Disease (ILD) | 143 | Turkey (Türkiye) | clinicaltrials.gov |
| September 11, 2025 | NCT07167238 | The Effect of Video Game-Based Exercise Training in Patients With Interstitial Lung Disease | Istinye University | Not applicable | Not yet recruiting | Interstitial Lung Disease | 42 | clinicaltrials.gov | |
| August 19, 2025 | NCT07130110 | BAL Contribution to Lung Cryo-TBB in ILD | Saglik Bilimleri Universitesi | Not applicable | Completed | Bronchoalveolar Lavage (BAL), Transbronchial Cryobiopsy, Interstitial Lung Disease (ILD) | 127 | Turkey (Türkiye) | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Assiut University | 4 | September 24, 2026 |
| Insmed Incorporated | 4 | September 4, 2026 |
| Boehringer Ingelheim | 4 | April 21, 2026 |
| Sohag University | 3 | September 22, 2026 |
| Istituto Clinico Humanitas | 3 | August 27, 2026 |
| Hospital de Granollers | 3 | July 23, 2026 |
| Ruijin Hospital | 3 | July 22, 2026 |
| Saglik Bilimleri Universitesi | 3 | January 6, 2026 |
| Gazi University | 3 | January 2, 2026 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 2 | October 6, 2026 |
| Mayo Clinic | 2 | September 14, 2026 |
| Pulmovant, Inc. | 2 | September 11, 2026 |
| Aveiro University | 2 | August 27, 2026 |
| The First Affiliated Hospital of Guangzhou Medical University | 2 | August 27, 2026 |
| University Hospitals, Leicester | 2 | August 21, 2026 |
| Chung-Ang University Hospital | 2 | July 20, 2026 |
| Istinye University | 2 | July 16, 2026 |
| University of California, San Francisco | 2 | June 29, 2026 |
| Assistance Publique - Hôpitaux de Paris | 2 | March 2, 2026 |
| China-Japan Friendship Hospital | 2 | February 12, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 49 | November 2, 2026 |
| Observational | 48 | November 9, 2026 |
| Phase 2 | 17 | September 15, 2026 |
| Phase 3 | 12 | September 18, 2026 |
| Phase 1 | 9 | October 14, 2026 |
| Phase 4 | 4 | October 6, 2026 |
| Phase 1/2 | 3 | May 20, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 33 | October 14, 2026 |
| France | 25 | October 14, 2026 |
| China | 21 | September 28, 2026 |
| United Kingdom | 16 | November 9, 2026 |
| Spain | 16 | July 23, 2026 |
| Italy | 15 | August 27, 2026 |
| Germany | 13 | October 14, 2026 |
| South Korea | 10 | July 20, 2026 |
| Australia | 10 | April 21, 2026 |
| Turkey (Türkiye) | 9 | July 16, 2026 |
| Poland | 8 | October 14, 2026 |
| Canada | 7 | April 21, 2026 |
| Portugal | 6 | November 2, 2026 |
| Belgium | 6 | October 14, 2026 |
| Netherlands | 6 | October 14, 2026 |
| Argentina | 6 | April 21, 2026 |
| Austria | 6 | April 21, 2026 |
| Japan | 6 | April 21, 2026 |
| Switzerland | 6 | March 30, 2026 |
| Israel | 5 | June 24, 2026 |
| Denmark | 5 | December 16, 2025 |
| Taiwan | 4 | August 12, 2026 |
| Brazil | 4 | April 21, 2026 |
| Mexico | 4 | April 21, 2026 |
| Romania | 4 | March 16, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.